G2/M phase-specific E3 ubiquitin-protein ligase (EC 2.3.2.26) (G2/M phase-specific HECT-type E3 ubiquitin transferase)
1_MNESK 6_ PGDSQ 11_ NLACV 16_ FCRKH 21_ DDCPN 26_ KYGEK 31_ KTKEK 36_ WNLTV 41_ HYYCL 46_ LMSSG 51_ IWQRG 56_ KEEEG 61_ VYGFL 66_ IEDIR 71_ KEVNR 76_ ASKLK 81_ CCVCK 86_ KNGAS 91_ IGCVA 96_ PRCKR 101_ SYHFP 106_ CGLQR 111_ ECIFQ 116_ FTGNF 121_ ASFCW 126_ DHRPV 131_ QIITS 136_ NNYRE 141_ SLPCT 146_ ICLEF 151_ IEPIP 156_ SYNIL 161_ RSPCC 166_ KNAWF 171_ HRDCL 176_ QVQAI 181_ NAGVF 186_ FFRCT 191_ ICNNS 196_ DIFQK 201_ EMLRM 206_ GIHIP 211_ EKDAS 216_ WELEE 221_ NAYQE 226_ LLQHY 231_ ERCDV 236_ RRCRC 241_ KEGRD 246_ YNAPD 251_ SKWEI 256_ KRCQC 261_ CGSSG 266_ THLAC 271_ SSLRS 276_ WEQNW 281_ ECLEC 286_ RGIIY 291_ NSGEF 296_ QKAKK 301_ HVLPN 306_ SNNVG 311_ ITDCL 316_ LEESS 321_ PKLPR 326_ QSPGS 331_ QSKDL 336_ LRQGS 341_ KFRRN 346_ VSTLL 351_ IELGF 356_ QIKKK 361_ TKRLY 366_ INKAN 371_ IWNSA 376_ LDAFR 381_ NRNFN 386_ PSYAI 391_ EVAYV 396_ IENDN 401_ FGSEH 406_ PGSKQ 411_ EFLSL 416_ LMQHL 421_ ENSSL 426_ FEGSL 431_ SKNLS 436_ LNSQA 441_ LKENL 446_ YYEAG 451_ KMLAI 456_ SLVHG 461_ GPSPG 466_ FFSKT 471_ LFNCL 476_ VYGPE 481_ NTQPI 486_ LDDVS 491_ DFDVA 496_ QIIIR 501_ INTAT 506_ TVADL 511_ KSIIN 516_ ECYNY 521_ LELIG 526_ CLRLI 531_ TTLSD 536_ KYMLV 541_ KDILG 546_ YHVIQ 551_ RVHTP 556_ FESFK 561_ QGLKT 566_ LGVLE 571_ KIQAY 576_ PEAFC 581_ SILCH 586_ KPESL 591_ SAKIL 596_ SELFT 601_ VHTLP 606_ DVKAL 611_ GFWNS 616_ YLQAV 621_ EDGKS 626_ TTTME 631_ DILIF 636_ ATGCS 641_ SIPPA 646_ GFKPT 651_ PSIEC 656_ LHVDF 661_ PVGNK 666_ CNNCL 671_ AIPIT 676_ NTYKE 681_ FQENM 686_ DFTIR 691_ NTLRL 696_ EKEES 701_SHYIG
1: E3 ubiquitin-protein ligase which accepts ubiquitin from an E2 ubiquitin-conjugating enzyme in the form of a thioester and then directly transfers the ubiquitin to targeted substrates. Essential in early embryonic development to prevent apoptotic death